128 related articles for article (PubMed ID: 8514542)
1. Combination of aziridinylbenzoquinone and cis-platinum with radiation therapy in the 9L rat brain tumor model.
Kimler BF; Liu C; Evans RG; Morantz RA
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):445-50. PubMed ID: 8514542
[TBL] [Abstract][Full Text] [Related]
2. Intracerebral chemotherapy in the 9L rat brain tumor model.
Kimler BF; Liu C; Evans RG; Morantz RA
J Neurooncol; 1992 Nov; 14(3):191-200. PubMed ID: 1281224
[TBL] [Abstract][Full Text] [Related]
3. The 9L rat brain tumor model for pre-clinical investigation of radiation-chemotherapy interactions.
Kimler BF
J Neurooncol; 1994; 20(2):103-9. PubMed ID: 7528789
[TBL] [Abstract][Full Text] [Related]
4. Combination of radiation therapy and intracranial bleomycin in the 9L rat brain tumor model.
Kimler BF; Martin DF; Evans RG; Morantz RA; Vats TS
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1115-21. PubMed ID: 1693363
[TBL] [Abstract][Full Text] [Related]
5. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
Slagel DE; Feola J; Houchens DP; Ovejera AA
Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
[TBL] [Abstract][Full Text] [Related]
6. Increased tumor cures using combined radiosurgery and BCNU in the treatment of 9l glioma in the rat brain.
Khil MS; Kolozsvary A; Apple M; Kim JH
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):511-6. PubMed ID: 10802380
[TBL] [Abstract][Full Text] [Related]
7. Decreased cytotoxicity of aziridinylbenzoquinone caused by polyamine depletion in 9L rat brain tumor cells in vitro.
Alhonen-Hongisto L; Deen DF; Marton LJ
Cancer Res; 1984 Jan; 44(1):39-42. PubMed ID: 6418379
[TBL] [Abstract][Full Text] [Related]
8. Experimental combination chemotherapy: intracarotid versus intravenous administration of aziridinylbenzoquinone, BCNU, and cisplatin in dogs.
Wright KC; Stephens LC; Wallace S; Savaraj N; Feun LG
Chemotherapy; 1987; 33(6):437-44. PubMed ID: 3428010
[TBL] [Abstract][Full Text] [Related]
9. Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, aziridinylbenzoquinone, and cis-platinum.
Schold SC; Rawlings CE; Bigner SH; Bigner DD
Neurosurgery; 1983 Jun; 12(6):672-7. PubMed ID: 6683794
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model.
Murphy S; Davey RA; Gu XQ; Haywood MC; McCann LA; Mather LE; Boyle FM
J Neurooncol; 2007 Nov; 85(2):181-9. PubMed ID: 17534579
[TBL] [Abstract][Full Text] [Related]
11. Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors. A Pediatric Oncology Group phase II study.
Castleberry RP; Ragab AH; Steuber CP; Kamen B; Toledano S; Starling K; Norris D; Burger P; Krischer JP
Invest New Drugs; 1990 Nov; 8(4):401-6. PubMed ID: 2084075
[TBL] [Abstract][Full Text] [Related]
12. Intralesionally implanted cisplatin plus systemic carmustine for the treatment of brain tumor in rats.
Kong Q; Kleinschmidt-DeMasters BK; Lillehei KO
J Surg Oncol; 1998 Oct; 69(2):76-82. PubMed ID: 9808509
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors.
Eagan RT; Dinapoli RP; Cascino TL; Scheithauer B; O'Neill BP; O'Fallon JR
J Neurooncol; 1987; 5(4):309-14. PubMed ID: 3440875
[TBL] [Abstract][Full Text] [Related]
14. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.
Coderre JA; Button TM; Micca PL; Fisher CD; Nawrocky MM; Liu HB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):643-52. PubMed ID: 7928496
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial and intravenous chemotherapy for the treatment of malignant glioma. Preliminary results.
Calvo FA; Pastor MA; Dy C; Alegría E; Antón Aparicio LM; Gil A; Harguindey S; Zubieta JL; Martinez Lage M
Am J Clin Oncol; 1985 Jun; 8(3):200-9. PubMed ID: 4050738
[TBL] [Abstract][Full Text] [Related]
16. A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors.
Chamberlain MC; Prados MD; Silver P; Levin VA
J Neurooncol; 1988 Dec; 6(4):319-23. PubMed ID: 3221259
[TBL] [Abstract][Full Text] [Related]
17. The role of minocycline in the treatment of intracranial 9L glioma.
Weingart JD; Sipos EP; Brem H
J Neurosurg; 1995 Apr; 82(4):635-40. PubMed ID: 7897527
[TBL] [Abstract][Full Text] [Related]
18. Effect of spirogermanium and radiation therapy on the 9L rat brain tumor model.
Kimler BF; Martin DF; Evans RG; Morantz RA; Vats TS
NCI Monogr; 1988; (6):115-8. PubMed ID: 3352753
[TBL] [Abstract][Full Text] [Related]
19. Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin.
Grossman R; Tyler B; Hwang L; Zadnik P; Lal B; Javaherian K; Brem H
J Neurosurg; 2011 Dec; 115(6):1139-46. PubMed ID: 21923243
[TBL] [Abstract][Full Text] [Related]
20. Drug cytotoxicity at elevated temperature. In vitro study on the U-87MG glioma cell line.
Da Silva VF; Raaphorst GP; Goyal R; Feeley M
J Neurosurg; 1987 Dec; 67(6):885-8. PubMed ID: 3681426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
